Last week, the tech-heavy Nasdaq Composite gained 0.96%, whereas The Dow Jones Industrial Average declined by 1.29%. The S&P ...

Enter the Zacks Rank. The Zacks Rank is a unique, proprietary stock-rating model that utilizes earnings estimate revisions to help investors build a winning portfolio. There are four main factors ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The Zacks Rank, which is a unique, proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, that makes building a winning portfolio easier.

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Premier, Inc. (PINC Quick Quote PINC - Free Report) : This healthcare improvement company has seen the Zacks Consensus Estimate ...

Over the past month, the estimate has changed +0.7%. With an impressive externally audited track record, our proprietary ...

Phathom Pharmaceuticals (PHAT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Lululemon (LULU) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

The Zacks Rank, which is a unique, proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, that makes building a winning portfolio easier.